Ubs Group Ag Myovant Sciences Ltd. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$24.03 - $27.02 $9.19 Million - $10.3 Million
382,529 Added 1337.14%
411,137 $11.1 Million
Q3 2022

Nov 10, 2022
SELL
$11.6 - $20.44 $643,336 - $1.13 Million
-55,460 Reduced 65.97%
28,608 $515,000
Q2 2022

Aug 10, 2022
SELL
$7.78 - $14.69 $526,807 - $994,703
-67,713 Reduced 44.61%
84,068 $1.04 Million
Q1 2022

May 16, 2022
SELL
$11.38 - $16.4 $943,936 - $1.36 Million
-82,947 Reduced 35.34%
151,781 $2.02 Million
Q4 2021

Feb 14, 2022
BUY
$14.31 - $23.87 $1.41 Million - $2.34 Million
98,190 Added 71.91%
234,728 $3.66 Million
Q3 2021

Nov 15, 2021
BUY
$18.94 - $26.99 $1.23 Million - $1.75 Million
64,689 Added 90.03%
136,538 $3.06 Million
Q2 2021

Aug 13, 2021
SELL
$17.07 - $24.56 $829,840 - $1.19 Million
-48,614 Reduced 40.36%
71,849 $1.64 Million
Q1 2021

May 12, 2021
SELL
$20.46 - $25.18 $2.09 Million - $2.57 Million
-101,953 Reduced 45.84%
120,463 $2.48 Million
Q4 2020

Feb 11, 2021
BUY
$13.8 - $27.62 $1.67 Million - $3.34 Million
120,752 Added 118.78%
222,416 $6.14 Million
Q3 2020

Nov 12, 2020
BUY
$14.05 - $22.6 $1.22 Million - $1.96 Million
86,778 Added 582.95%
101,664 $1.43 Million
Q2 2020

Jul 31, 2020
BUY
$7.34 - $20.84 $76,695 - $217,757
10,449 Added 235.5%
14,886 $307,000
Q1 2020

May 01, 2020
SELL
$6.55 - $14.76 $49,766 - $112,146
-7,598 Reduced 63.13%
4,437 $34,000
Q4 2019

Feb 14, 2020
BUY
$4.2 - $19.21 $20,517 - $93,840
4,885 Added 68.32%
12,035 $187,000
Q3 2019

Nov 14, 2019
BUY
$5.19 - $9.46 $34,295 - $62,511
6,608 Added 1219.19%
7,150 $37,000
Q2 2019

Aug 14, 2019
SELL
$8.69 - $25.0 $5,648 - $16,250
-650 Reduced 54.53%
542 $5,000
Q1 2019

May 14, 2019
SELL
$16.83 - $24.45 $4,140 - $6,014
-246 Reduced 17.11%
1,192 $28,000
Q4 2018

Feb 14, 2019
BUY
$15.01 - $25.2 $2,191 - $3,679
146 Added 11.3%
1,438 $23,000
Q3 2018

Nov 14, 2018
BUY
$19.33 - $26.78 $24,974 - $34,599
1,292 New
1,292 $34,000
Q2 2018

Aug 14, 2018
SELL
$19.2 - $25.14 $19,680 - $25,768
-1,025 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$12.46 - $21.32 $12,771 - $21,853
1,025 New
1,025 $22,000
Q4 2017

Feb 14, 2018
SELL
$11.37 - $16.4 $13,462 - $19,417
-1,184 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$9.93 - $15.47 $10,615 - $16,537
1,069 Added 929.57%
1,184 $18,000
Q2 2017

Aug 14, 2017
SELL
N/A
-1,628 Reduced 93.4%
115 $1,000
Q1 2017

Nov 14, 2017
BUY
N/A
1,743
1,743 $20,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email